Additional Details
-
A Study to Investigate Leramistat in Patients With IPF
MedStar Georgetown University HospitalWashington DC. 20007 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
UCLA Health Westwood Medical PlazaWestwood CA. 90095 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Stamford Health Medical Group - Stamford - 29 Hospital Plaza Suite 605Stamford CT. 06904 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Avanza Medical Research CenterPensacola FL. 32503 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Scripps Clinic Torrey PinesLa Jolla CA. 92037-1027 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
The University of Texas Health San Antonio Medical Arts & Research CenterSan Antonio TX. 78229-3931 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Emory ClinicAtlanta GA. 30322-1013 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Local Institution - 0526Tucson AZ. 85723-3001 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Loyola University Health SystemMaywood IL. 60153-3328 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
University of Cincinnati College Of MedicineCincinnati OH. 45267 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Local Institution - 0525Reno NV. 89502-1576 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
St. Paul's HospitalVancouver BC. V6Z 1Y6 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
University of Southern California (USC) - Keck School of Medicine (KSOM) - Transplant ClinicLos Angeles CA. 90033-5313 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Local Institution - 0517Miami FL. 33136-1124 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
David Geffen School of Medicine at UCLALos Angeles CA. 90095-3075 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Christiana Care Pulmonary Associates - NewarkNewark DE. 19713-1337 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Velocity Clinical Research - DurhamGreenville SC. 29615 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Northwestern Memorial HospitalChicago IL. 60611 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Local Institution - 0514Saint-Charles-Borromee QC. J6E 6A9 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Massachusetts General HospitalBoston MA. 02114-2621